Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System

Abstract

A receptor affinity-based grouping not only reflects compound pharmacology but also detects meaningful clinical differences. This approach has the potential to benefit both patients and researchers by guiding treatment and informing drug development.